Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine

Veterinary Microbiology

Volumn 163, Issue 3-4, 2013, Pages 248-256

  Fan, Yi Chin ^a   Chen, Jo Mei ^a   Chen, Yi Ying ^a   Lin, Jen Wei ^a   Chiou, Shyan Song ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Genotype replacement; Japanese encephalitis; Live attenuated vaccine; Protective threshold

Indexed keywords

AT 222; ENVELOPE PROTEIN; JAPANESE ENCEPHALITIS VACCINE; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; GENOTYPE; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; TAIWAN; VIRUS STRAIN;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS PROTECTION; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; GENOTYPE; JAPANESE ENCEPHALITIS VACCINES; SWINE; SWINE DISEASES; TAIWAN; VACCINATION; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS;

JAPANESE ENCEPHALITIS VIRUS; SUIDAE;

EID: 84875383760     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.01.017     Document Type: Article

References (41)

1. Ashok M.S., Rangarajan P.N. Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies. Vaccine 1999, 18:68-75.
2. Beasley D.W., Li L., Suderman M.T., Guirakhoo F., Trent D.W., Monath T.P., Shope R.E., Barrett A.D. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine 2004, 22:3722-3726.
3. Bista M.B., Banerjee M.K., Shin S.H., Tandan J.B., Kim M.H., Sohn Y.M., Ohrr H.C., Tang J.L., Halstead S.B. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 2001, 358:791-795.
4. Brien J.D., Austin S.K., Sukupolvi-Petty S., O'Brien K.M., Johnson S., Fremont D.H., Diamond M.S. Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J. Virol. 2010, 84:10630-10643.
5. Campbell G.L., Hills S.L., Fischer M., Jacobson J.A., Hoke C.H., Hombach J.M., Marfin A.A., Solomon T., Tsai T.F., Tsu V.D., Ginsburg A.S. Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organ. 2011, 89:766-774. 774A-774E.
6. Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990, 44:649-688.
7. Chen S.P. Molecular phylogenetic and evolutionary analysis of Japanese encephalitis virus in China. Epidemiol. Infect. 2012, 140:1637-1643.
8. Chen Y.Y., Fan Y.C., Tu W.C., Chang R.Y., Shih C.C., Lu I.H., Chien M.S., Lee W.C., Chen T.H., Chang G.J., Chiou S.S. Japanese encephalitis virus genotype replacement, Taiwan, 2009-2010. Emerg. Infect. Dis. 2011, 17:2354-2356.
9. Chiou S.S., Chen W.J. Mutations in the NS3 gene and 3'-NCR of Japanese encephalitis virus isolated from an unconventional ecosystem and implications for natural attenuation of the virus. Virology 2001, 289:129-136.
10. Chiou S.S., Chen W.J. Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: generation of attenuated strains of the virus. Vaccine 2007, 26:15-23.
11. Chiou S.S., Fan Y.C., Crill W.D., Chang R.Y., Chang G.J. Mutation analysis of the cross-reactive epitopes of Japanese encephalitis virus envelope glycoprotein. J. Gen. Virol. 2012, 93:1185-1192.
12. Chiou S.S., Liu H., Chuang C.K., Lin C.C., Chen W.J. Fitness of Japanese encephalitis virus to Neuro-2a cells is determined by interactions of the viral envelope protein with highly sulfated glycosaminoglycans on the cell surface. J. Med. Virol. 2005, 76:583-592.
13. Chiou S.S., Tsai K.H., Huang C.G., Liao Y.K., Chen W.J. High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus. Vaccine 2007, 25:1437-1443.
14. Erlanger T.E., Weiss S., Keiser J., Utzinger J., Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg. Infect. Dis. 2009, 15:1-7.
15. Fan Y.C., Chen J.M., Chiu H.C., Chen Y.Y., Lin J.W., Shih C.C., Chen C.M., Chang C.C., Chang G.J., Chiou S.S. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine. PLoS Negl. Trop. Dis. 2012, 6:e1834.
16. Fischer M., Lindsey N., Staples J.E., Hills S. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2010, 59:1-27.
17. Fulmali P.V., Sapkal G.N., Athawale S., Gore M.M., Mishra A.C., Bondre V.P. Introduction of Japanese encephalitis virus genotype I, India. Emerg. Infect. Dis. 2011, 17:319-321.
18. Halstead S.B., Thomas S.J. New vaccines for Japanese encephalitis. Curr. Infect. Dis. Rep. 2010, 12:174-180.
19. Halstead S.B., Thomas S.J. New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Rev. Vaccines 2011, 10:355-364.
20. Huang J.H., Lin T.H., Teng H.J., Su C.L., Tsai K.H., Lu L.C., Lin C., Yang C.F., Chang S.F., Liao T.L., Yu S.K., Cheng C.H., Chang M.C., Hu H.C., Shu P.Y. Molecular epidemiology of Japanese encephalitis virus, Taiwan. Emerg. Infect. Dis. 2010, 16:876-878.
21. Liu X., Yu Y., Li M., Liang G., Wang H., Jia L., Dong G. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China. Vaccine 2011, 29:2127-2130.
22. Luca V.C., Abimansour J., Nelson C.A., Fremont D.H. Crystal structure of the Japanese encephalitis virus envelope protein. J. Virol. 2012, 86:2337-2346.
23. Ma S.P., Yoshida Y., Makino Y., Tadano M., Ono T., Ogawa M. Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan. Am. J. Trop. Med. Hyg. 2003, 69:151-154.
24. Mackenzie J.S., Gubler D.J., Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 2004, 10:S98-S109.
25. Morita K. Molecular epidemiology of Japanese encephalitis in East Asia. Vaccine 2009, 27:7131-7132.
26. Nga P.T., del Carmen Parquet M., Cuong V.D., Ma S.P., Hasebe F., Inoue S., Makino Y., Takagi M., Nam V.S., Morita K. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J. Gen. Virol. 2004, 85:1625-1631.
27. Nitatpattana N., Dubot-Peres A., Gouilh M.A., Souris M., Barbazan P., Yoksan S., de Lamballerie X., Gonzalez J.P. Change in Japanese encephalitis virus distribution, Thailand. Emerg. Infect. Dis. 2008, 14:1762-1765.
28. Pan X.L., Liu H., Wang H.Y., Fu S.H., Liu H.Z., Zhang H.L., Li M.H., Gao X.Y., Wang J.L., Sun X.H., Lu X.J., Zhai Y.G., Meng W.S., He Y., Wang H.Q., Han N., Wei B., Wu Y.G., Feng Y., Yang D.J., Wang L.H., Tang Q., Xia G., Kurane I., Rayner S., Liang G.D. Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J. Virol. 2011, 85:9847-9853.
29. Parida M., Dash P.K., Tripathi N.K., Ambuj, Sannarangaiah S., Saxena P., Agarwal S., Sahni A.K., Singh S.P., Rathi A.K., Bhargava R., Abhyankar A., Verma S.K., Rao P.V., Sekhar K. Japanese encephalitis outbreak, India, 2005. Emerg. Infect. Dis. 2006, 12:1427-1430.
30. Saito M., Taira K., Itokazu K., Mori N. Recent change of the antigenicity and genotype of Japanese encephalitis viruses distributed on Okinawa Island, Japan. Am. J. Trop. Med. Hyg. 2007, 77:737-746.
31. Shrestha B., Brien J.D., Sukupolvi-Petty S., Austin S.K., Edeling M.A., Kim T., O'Brien K.M., Nelson C.A., Johnson S., Fremont D.H., Diamond M.S. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog. 2010, 6:e1000823.
32. Solomon T., Ni H., Beasley D.W., Ekkelenkamp M., Cardosa M.J., Barrett A.D. Origin and evolution of Japanese encephalitis virus in southeast Asia. J. Virol. 2003, 77:3091-3098.
33. Sukupolvi-Petty S., Austin S.K., Engle M., Brien J.D., Dowd K.A., Williams K.L., Johnson S., Rico-Hesse R., Harris E., Pierson T.C., Fremont D.H., Diamond M.S. Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J. Virol. 2010, 84:9227-9239.
34. Tang W.F., Ogawa M., Eshita Y., Aono H., Makino Y. Molecular evolution of Japanese encephalitis virus isolates from swine in Oita, Japan during 1980-2009. Infect. Genet. Evol. 2010, 10:329-336.
35. Ueba N., Kimura T., Nakajima S., Kurimura T., Kitaura T. Field experiments on live attenuated Japanese encephalitis virus vaccine for swine. Biken J. 1978, 21:95-103.
36. van den Hurk A.F., Ritchie S.A., Mackenzie J.S. Ecology and geographical expansion of Japanese encephalitis virus. Annu. Rev. Entomol. 2009, 54:17-35.
37. Van Gessel Y., Klade C.S., Putnak R., Formica A., Krasaesub S., Spruth M., Cena B., Tungtaeng A., Gettayacamin M., Dewasthaly S. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO((R))) induced neutralizing antibody titers. Vaccine 2011, 29:5925-5931.
38. Wu Y.C., Huang Y.S., Chien L.J., Lin T.L., Yueh Y.Y., Tseng W.L., Chang K.J., Wang G.R. The epidemiology of Japanese encephalitis on Taiwan during 1966-1997. Am. J. Trop. Med. Hyg. 1999, 61:78-84.
39. Yasui K. Neuropathogenesis of Japanese encephalitis virus. J. Neurovirol. 2002, 8(Suppl. 2):112-114.
40. Yun S.M., Cho J.E., Ju Y.R., Kim S.Y., Ryou J., Han M.G., Choi W.Y., Jeong Y.E. Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005. Virol J. 2010, 7:127.
41. Zhang J.S., Zhao Q.M., Guo X.F., Zuo S.Q., Cheng J.X., Jia N., Wu C., Dai P.F., Zhao J.Y. Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009. PLoS One 2011, 6:e16418.